RNA sequencing (RNA-Seq) and its application in ovarian cancer

Jinglu Wang1, Dylan C Dean2, Francis J Hornicek2

  • 1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China; Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

Gynecologic Oncology
|October 10, 2018
PubMed

Insights

RNA sequencing (RNA-Seq) offers advanced insights into ovarian cancer molecular pathogenesis, outperforming older methods for early detection and identifying drug resistance markers. This technology enhances understanding of gene expression and molecular pathways for improved ovarian cancer research.

Area of Science:

  • Genomics and Molecular Biology
  • Oncology
  • Biotechnology

Background:

  • Ovarian cancer is a leading cause of gynecological cancer mortality, with early detection biomarkers and drug resistance remaining significant challenges.
  • Advances in RNA sequencing (RNA-Seq) using Next Generation Sequencing technology have significantly improved our understanding of ovarian cancer's molecular basis.

Purpose of the Study:

  • To review the advantages of RNA sequencing (RNA-Seq) over traditional transcriptomics methods in ovarian cancer research.
  • To highlight recent applications of RNA-Seq in understanding ovarian cancer's molecular pathogenesis, detection, and treatment resistance.

Main Methods:

  • Comparative analysis of RNA sequencing (RNA-Seq) with hybridization-based microarray and Sanger sequencing.
  • Review of studies utilizing RNA-Seq for gene expression quantification, alternative splicing, mutation identification, and novel transcript discovery in ovarian cancer.

Main Results:

  • RNA-Seq provides higher resolution, greater transcriptome complexity, reduced background noise, and a broader dynamic range compared to older methods.
  • RNA-Seq facilitates identification of alternatively spliced genes, fusion genes, mutations, allele-specific expression, novel transcripts, and non-coding RNAs.
  • Applications in ovarian cancer include earlier detection, pathological origin determination, and defining aberrant genes and molecular pathways.

Conclusions:

  • RNA sequencing (RNA-Seq) is a powerful tool for advancing ovarian cancer research due to its comprehensive data output and analytical capabilities.
  • The adoption of RNA-Seq is crucial for overcoming challenges in early detection and drug resistance, paving the way for improved patient outcomes.

Related Concept Videos

RNA-seq03:21

RNA-seq

RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
12.1K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.1K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.6K
RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
35.7K
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.9K
Bacterial RNA Polymerase00:43

Bacterial RNA Polymerase

Unlike eukaryotes, bacteria use a single RNA Polymerase (RNAP) to transcribe all genes. The different subunits of bacterial RNAPhave distinct functions. The multisubunit structure of the bacterial RNAP helps the enzyme to maintain catalytic function, facilitate assembly, interact with DNA and RNA, and self-regulate its activity.
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
32.8K